Biolase has launched the Waterlase Perio Academy (WPA) to help clinicians provide periodontal and implant services with improved patient outcomes through the continued adoption of laser technology, according to the company.
Like Biolase’s Waterlase Endo Academy, the WPA will foster peer-led learning with ongoing mentorship from WPA’s leading clinicians, featuring online meetings and case reviews by experts in the field, the company said. The WPA will be open to all periodontists who use the Waterlase technology.
“Launching an academy devoted to supporting the growth and timely needs of periodontists directly aligns with Biolase’s mission of advancing dentistry,” said John Beaver, president and CEO of Biolase.
“Periodontists are actively seeking ways to manage both periodontal and implant diseases, as the incidence of gum disease with bone loss has increased in the adult population,” Beaver continued.
“Periodontitis can often be linked to systemic diseases, from inflammatory cardiac disease to recent COVID-19 infections, further stressing the need for innovative solutions and expert collaboration among dental professionals,” Beaver said.
As part of the WPA, members will have access to facilitated discussions around complex cases, ongoing mentorship from leading clinicians, didactic online meetings, and interactive case reviews, Biolase said.
The WPA’s leadership includes experienced periodontists such as Drs. Paul Chang, Curry Leavitt, Stephen John, Todd Jorgenson, James Papp, and Bret Dyer. Virtual progressive training sessions also will be added in real time to address new procedures as they arise, Biolase said, and members will be among the first clinicians to know when the company releases new products.
“Periodontists have seen a significant increase in peri-implant disease, which is alarming due to the number of new dental implants being placed each year and existing aging dental implants currently in function,” said Chang.
“As clinicians, it is critical for our growth and our patients’ outcomes that we collaborate around clinically proven solutions, including Biolase’s established implant repair protocol, which has shown significant success in decontamination,” Chang said.
“This method even allows new bone formation around the previously contaminated implant. No other company method has been shown to do this more predictably than implant repair protocol,” Chang said.
Waterlase lasers enable clinicians to decontaminate diseased implants and provide opportunities to return the implant to a healthy state, Biolase said. Peer-reviewed studies continue to support evidence that periodontal and implant disease can be managed with minimally invasive laser procedures, the company continued, resulting in excellent patient-reported outcomes.